SignalCorporate
Astellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook
Astellas reported GAAP EPS of ¥134.47 and revenue of ¥1270.86B while updating its FY2027 outlook.
What changed
Astellas reported GAAP EPS of ¥134.47 and revenue of ¥1270.86B while updating its FY2027 outlook.
Why it matters
Astellas reported GAAP EPS of ¥134.47 and revenue of ¥1270.86B while updating its FY2027 outlook. — impact context not separately stored; see What changed.